Literature DB >> 13766075

Resistance and cross-resistance of Escherichia coli mutants to anticancer agents. 1-Methyl-3-nitro-1-nitrosoguanidine.

J D MANDELL, P L WOODY, J GREENBERG.   

Abstract

Entities:  

Keywords:  AMIDINES/pharmacology; ANTINEOPLASTIC AGENTS; ESCHERICHIA COLI/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 13766075      PMCID: PMC279024          DOI: 10.1128/jb.81.3.419-424.1961

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  20 in total

1.  Selective inhibition of formation of deoxyribonucleic acid in Escherichia coli by mitomycin C.

Authors:  S SHIBA; A TERAWAKI; T TAGUCHI; J KAWAMATA
Journal:  Nature       Date:  1959-04-11       Impact factor: 49.962

2.  The activity of nitrosoguanidines against ascites tumors in mice.

Authors:  M O GREENE; J GREENBERG
Journal:  Cancer Res       Date:  1960-09       Impact factor: 12.701

3.  Mutagenic effect of azaserine in relation to azaserine resistance in Escherichia coli.

Authors:  V N IYER; W SZYBALSKI
Journal:  Science       Date:  1959-03-27       Impact factor: 47.728

4.  Inhibitory effect of mitomycin C upon experimental tumors.

Authors:  I USUBUCH; S OBOSHI; R TSUCHIDA; S TAZAWA; N NARITA; H TANABE; F TAKAHASHI; T MATSUMOTO; K NARITA
Journal:  Gan       Date:  1957-12

5.  Effect of nitrogen and sulfur mustard on nucleic acid synthesis in Escherichia coli.

Authors:  F M HAROLD; Z Z ZIPORIN
Journal:  Biochim Biophys Acta       Date:  1958-06

6.  Cytological analysis of ultraviolet-irradiated Escherichia coli. III. Reactions of a sensitive strain and its resistant mutants.

Authors:  P E HARTMAN; S MUDD; J I PAYNE; A W PHILLIPS
Journal:  J Bacteriol       Date:  1956-10       Impact factor: 3.490

7.  Genetic studies on microbial cross-resistance to toxic agents. III. Cross-resistance of Mycobacterium ranae to twenty-eight antimycobacterial agents.

Authors:  W SZYBALSKI; V BRYSON
Journal:  Am Rev Tuberc       Date:  1954-02

8.  Some Effects of Penicillin on Intestinal Bacteria.

Authors:  A R Thomas; M Levine
Journal:  J Bacteriol       Date:  1945-06       Impact factor: 3.490

9.  Recent contributions to the pharmacology of bis(2-haloethyl) amines and sulfides.

Authors:  F S PHILIPS
Journal:  J Pharmacol Exp Ther       Date:  1950-08       Impact factor: 4.030

10.  THE MECHANISM OF CHEMICAL MUTAGENESIS. I. KINETIC STUDIES ON THE ACTION OF TRIETHYLENE MELAMINE (TEM) AND AZASERINE.

Authors:  V N Iyer; W Szybalski
Journal:  Proc Natl Acad Sci U S A       Date:  1958-05       Impact factor: 11.205

View more
  7 in total

1.  Filament formation in radio-resistant mutants of Escherichia coli S after treatment with ultraviolet light and radiomimetic agents.

Authors:  J CURRY; J GREENBERG
Journal:  J Bacteriol       Date:  1962-01       Impact factor: 3.490

2.  Cross-resistance relationships in Escherichia coli between ultraviolet radiation and nitrous acid.

Authors:  A Zampieri; J Greenberg
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

3.  [Relations between the resistance to streptomycin and irradiation of Azotobacter chroococcum Beij].

Authors:  H P Müller
Journal:  Arch Mikrobiol       Date:  1966-02-01

4.  Mutations determining mitomycin resistance in Bacillus subtilis.

Authors:  V N Iyer
Journal:  J Bacteriol       Date:  1966-12       Impact factor: 3.490

5.  RESISTANCE AND CROSS-RESISTANCE OF ESCHERICHIA COLI S MUTANTS TO THE RADIOMIMETIC AGENT PROFLAVINE.

Authors:  P WOODY-KARRER; J GREENBERG
Journal:  J Bacteriol       Date:  1964-03       Impact factor: 3.490

6.  Isolation of mutants of Escherichia coli with increased resistance to alkylating agents: mutants deficient in thiols and mutants constitutive for the adaptive response.

Authors:  B Sedgwick; P Robins
Journal:  Mol Gen Genet       Date:  1980

7.  RESISTANCE AND CROSS RESISTANCE OF ESCHERICHIA COLI S MUTANTS TO THE RADIOMIMETIC AGENT NITROFURAZONE.

Authors:  P WOODY-KARRER; J GREENBERG
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.